StonvexLoading…
StonvexStonvexStonvexCore line items from REYN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $954.39M | $877.00M | $3.72B | $2.69B | $1.76B |
Operating Income | Not available | $77.00M | $393.00M | $240.00M | $138.00M |
Net Income | Not available | $59.00M | $301.00M | $184.00M | $73.00M |
EPS (Diluted) | $0.41 | $0.28 | $1.43 | $0.87 | $0.50 |
Total Assets | Not available | $4.93B | $4.94B | $4.90B | $4.86B |
Total Liabilities | Not available | $2.67B | $2.68B | $2.72B | $2.71B |
Cash & Equivalents | Not available | $71.00M | $147.00M | $53.00M | $57.00M |
Free Cash Flow OCF − CapEx | Not available | $27.00M | $316.00M | $116.00M | $68.00M |
Shares Outstanding | Not available | 210.70M | 210.70M | 210.30M | 210.30M |